
Frontiers news
21 Jul 2025
Frontiers supports Alzheimer's research with expert-led interview series focused on open data and drug discovery
Frontiers today announces the launch of a new interview series ‘Empowering proteomics and transcriptomics in Alzheimer’s drug discovery’. The series is hosted by Dr Ornit Chiba-Falek, Specialty Chief Editor of Frontiers in Molecular Medicine and Division Chief of Translational Brain Sciences in the Department of Neurology at Duke University, and Dr Ara Khachaturian, Executive Vice President of the Campaign to Prevent Alzheimer’s Disease.